Package 60219-1165-7

Brand: abiraterone acetate

Generic: abiraterone
NDC Package

Package Facts

Identity

Package NDC 60219-1165-7
Digits Only 6021911657
Product NDC 60219-1165
Product ID 60219-1165_7f57b4d0-9c5f-4714-830b-c7736c3d8b2d
Description

120 TABLET in 1 BOTTLE (60219-1165-7)

Marketing

Marketing Status
Marketed Since 2023-04-28
Brand abiraterone acetate
Generic abiraterone
Sample Package No

Linked Drug Pages (1)

Abiraterone Acetate, ABIRATERONE ACETATE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "7f57b4d0-9c5f-4714-830b-c7736c3d8b2d", "openfda": {"upc": ["0360219116573", "0360219175464"], "unii": ["EM5OCB9YJ6"], "rxcui": ["1100075", "1918042"], "spl_set_id": ["6fda6b92-59ed-4180-af68-94052a5e82cf"], "manufacturer_name": ["Amneal Pharmaceuticals NY LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "120 TABLET in 1 BOTTLE (60219-1165-7)", "package_ndc": "60219-1165-7", "marketing_start_date": "20230428"}], "brand_name": "Abiraterone Acetate", "product_id": "60219-1165_7f57b4d0-9c5f-4714-830b-c7736c3d8b2d", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 17A1 Inhibitor [EPC]", "Cytochrome P450 17A1 Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]"], "product_ndc": "60219-1165", "generic_name": "Abiraterone", "labeler_name": "Amneal Pharmaceuticals NY LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Abiraterone Acetate", "active_ingredients": [{"name": "ABIRATERONE ACETATE", "strength": "250 mg/1"}], "application_number": "ANDA208327", "marketing_category": "ANDA", "marketing_start_date": "20230428", "listing_expiration_date": "20261231"}